Yigal Nochomovitz
Stock Analyst at Citi
(4.78)
# 575
Out of 4,668 analysts
778
Total ratings
51.8%
Success rate
16.3%
Average return
Main Sectors:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical | Maintained: Buy | $45 → $58 | $25.32 | +129.07% | 31 | Aug 20, 2026 | |
| EYPT EyePoint | Maintained: Buy | $35 → $17 | $5.40 | +214.81% | 4 | Aug 18, 2026 | |
| AVBP ArriVent BioPharma | Maintained: Buy | $43 → $40 | $29.18 | +37.08% | 14 | Aug 14, 2026 | |
| LENZ LENZ Therapeutics | Maintained: Buy | $20 → $10 | $4.66 | +114.59% | 15 | Aug 13, 2026 | |
| CRBU Caribou Biosciences | Rated: Buy | $8 | $1.61 | +396.89% | 23 | Aug 13, 2026 | |
| LGND Ligand Pharmaceuticals | Maintained: Buy | $387 → $390 | $287.39 | +35.70% | 5 | Aug 12, 2026 | |
| STTK Shattuck Labs | Maintained: Buy | $18 | $7.25 | +148.28% | 14 | Aug 12, 2026 | |
| ACAD ACADIA Pharmaceuticals | Maintained: Buy | $35 → $39 | $29.04 | +34.30% | 8 | Aug 10, 2026 | |
| ARDX Ardelyx | Maintained: Buy | $14 → $11 | $3.90 | +182.05% | 25 | Aug 10, 2026 | |
| ZYME Zymeworks | Maintained: Buy | $37 | $26.57 | +39.25% | 33 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $21 | $9.03 | +132.69% | 25 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $62 → $59 | $10.90 | +441.28% | 14 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $1.36 | +414.71% | 20 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $9.10 | +53.85% | 7 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $81 → $83 | $45.25 | +83.43% | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $85 | $64.46 | +31.86% | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $453 → $466 | $369.16 | +26.23% | 8 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 → $45 | $26.02 | +72.94% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $57 | $19.75 | +188.61% | 18 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $378 → $386 | $337.02 | +14.53% | 12 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $246 → $249 | $152.93 | +62.82% | 11 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $82 → $88 | $58.12 | +51.41% | 26 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $24.04 | +45.62% | 4 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $12.43 | +221.80% | 19 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $29.52 | +52.44% | 30 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $13 | $19.22 | -32.36% | 13 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 | $12.35 | +110.53% | 9 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 | $97.07 | +49.38% | 2 | Jun 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $12.96 | +62.04% | 1 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $31.62 | +29.66% | 11 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.3 → $3.1 | $2.18 | +42.20% | 33 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $17 → $16 | $13.88 | +15.27% | 19 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $39.11 | +66.20% | 19 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 → $9 | $14.36 | -37.33% | 5 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $26.23 | +60.12% | 2 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 → $8 | $10.99 | -27.21% | 20 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $1.42 | +604.23% | 7 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2 → $4 | $2.27 | n/a | 10 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $11 | $3.47 | n/a | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $11 → $8 | $1.32 | n/a | 8 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $10 | $0.022 | n/a | 5 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $14 | $4.07 | n/a | 16 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.5 → $1.2 | $2.74 | n/a | 18 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $2.45 | n/a | 11 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.50 | n/a | 16 | Dec 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $35 → $10 | $9.38 | n/a | 17 | Nov 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $8 | $2.09 | n/a | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.5 → $1 | $0.88 | n/a | 6 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.4 → $0.25 | $20.19 | n/a | 9 | Aug 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $63 | $70.52 | n/a | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $2 | $1.53 | n/a | 3 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 | €1.78 | n/a | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 → $8 | $58.92 | n/a | 5 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 → $11 | $9.11 | n/a | 24 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $26 → $2 | $1.22 | n/a | 5 | Aug 21, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $9 | $0.9194 | n/a | 1 | Mar 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 4 | Dec 29, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $0.00001 | n/a | 6 | Aug 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.82 | n/a | 2 | Apr 27, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $1.50 | n/a | 6 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $11.09 | n/a | 6 | Mar 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 | $1.82 | n/a | 5 | Mar 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $1.12 | n/a | 1 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.40 | n/a | 3 | Nov 23, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2,366.00 | n/a | 3 | Nov 21, 2014 |
Ultragenyx Pharmaceutical
Aug 20, 2026
Maintained: Buy
Price Target: $45 → $58
Current: $25.32
Upside: +129.07%
EyePoint
Aug 18, 2026
Maintained: Buy
Price Target: $35 → $17
Current: $5.40
Upside: +214.81%
ArriVent BioPharma
Aug 14, 2026
Maintained: Buy
Price Target: $43 → $40
Current: $29.18
Upside: +37.08%
LENZ Therapeutics
Aug 13, 2026
Maintained: Buy
Price Target: $20 → $10
Current: $4.66
Upside: +114.59%
Caribou Biosciences
Aug 13, 2026
Rated: Buy
Price Target: $8
Current: $1.61
Upside: +396.89%
Ligand Pharmaceuticals
Aug 12, 2026
Maintained: Buy
Price Target: $387 → $390
Current: $287.39
Upside: +35.70%
Shattuck Labs
Aug 12, 2026
Maintained: Buy
Price Target: $18
Current: $7.25
Upside: +148.28%
ACADIA Pharmaceuticals
Aug 10, 2026
Maintained: Buy
Price Target: $35 → $39
Current: $29.04
Upside: +34.30%
Ardelyx
Aug 10, 2026
Maintained: Buy
Price Target: $14 → $11
Current: $3.90
Upside: +182.05%
Zymeworks
Aug 10, 2026
Maintained: Buy
Price Target: $37
Current: $26.57
Upside: +39.25%
Aug 10, 2026
Maintained: Buy
Price Target: $24 → $21
Current: $9.03
Upside: +132.69%
Aug 10, 2026
Rated: Buy
Price Target: $62 → $59
Current: $10.90
Upside: +441.28%
Aug 10, 2026
Rated: Buy
Price Target: $7
Current: $1.36
Upside: +414.71%
Aug 7, 2026
Reiterated: Buy
Price Target: $14
Current: $9.10
Upside: +53.85%
Aug 6, 2026
Maintained: Buy
Price Target: $81 → $83
Current: $45.25
Upside: +83.43%
Aug 6, 2026
Maintained: Buy
Price Target: $70 → $85
Current: $64.46
Upside: +31.86%
Aug 6, 2026
Rated: Buy
Price Target: $453 → $466
Current: $369.16
Upside: +26.23%
Aug 6, 2026
Maintained: Buy
Price Target: $44 → $45
Current: $26.02
Upside: +72.94%
Aug 5, 2026
Maintained: Buy
Price Target: $57
Current: $19.75
Upside: +188.61%
Aug 4, 2026
Maintained: Buy
Price Target: $378 → $386
Current: $337.02
Upside: +14.53%
Aug 3, 2026
Maintained: Buy
Price Target: $246 → $249
Current: $152.93
Upside: +62.82%
Aug 3, 2026
Reiterated: Buy
Price Target: $82 → $88
Current: $58.12
Upside: +51.41%
Aug 3, 2026
Maintained: Buy
Price Target: $35
Current: $24.04
Upside: +45.62%
Jul 24, 2026
Reiterated: Buy
Price Target: $40
Current: $12.43
Upside: +221.80%
Jul 22, 2026
Maintained: Buy
Price Target: $45
Current: $29.52
Upside: +52.44%
Jul 20, 2026
Maintained: Sell
Price Target: $13
Current: $19.22
Upside: -32.36%
Jun 30, 2026
Maintained: Buy
Price Target: $26
Current: $12.35
Upside: +110.53%
Jun 14, 2026
Maintained: Buy
Price Target: $145
Current: $97.07
Upside: +49.38%
May 18, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $12.96
Upside: +62.04%
May 13, 2026
Reiterated: Buy
Price Target: $41
Current: $31.62
Upside: +29.66%
May 11, 2026
Maintained: Buy
Price Target: $2.3 → $3.1
Current: $2.18
Upside: +42.20%
May 5, 2026
Rated: Buy
Price Target: $17 → $16
Current: $13.88
Upside: +15.27%
Apr 13, 2026
Maintained: Buy
Price Target: $65
Current: $39.11
Upside: +66.20%
Mar 10, 2026
Rated: Buy
Price Target: $7 → $9
Current: $14.36
Upside: -37.33%
Mar 9, 2026
Maintained: Buy
Price Target: $42
Current: $26.23
Upside: +60.12%
Mar 4, 2026
Rated: Hold
Price Target: $7 → $8
Current: $10.99
Upside: -27.21%
Sep 3, 2025
Maintained: Buy
Price Target: $10
Current: $1.42
Upside: +604.23%
Mar 7, 2025
Upgraded: Buy
Price Target: $2 → $4
Current: $2.27
Upside: n/a
Dec 11, 2024
Maintained: Buy
Price Target: $16 → $11
Current: $3.47
Upside: n/a
Dec 4, 2024
Rated: Buy
Price Target: $11 → $8
Current: $1.32
Upside: n/a
Sep 12, 2024
Maintained: Buy
Price Target: $12 → $10
Current: $0.022
Upside: n/a
Aug 15, 2024
Maintained: Buy
Price Target: $16 → $14
Current: $4.07
Upside: n/a
Jun 17, 2024
Maintained: Hold
Price Target: $3.5 → $1.2
Current: $2.74
Upside: n/a
May 15, 2024
Maintained: Buy
Price Target: $10
Current: $2.45
Upside: n/a
Dec 4, 2023
Maintained: Buy
Price Target: $8
Current: $1.50
Upside: n/a
Nov 22, 2023
Maintained: Sell
Price Target: $35 → $10
Current: $9.38
Upside: n/a
Sep 18, 2023
Maintained: Buy
Price Target: $12 → $8
Current: $2.09
Upside: n/a
Sep 18, 2023
Maintained: Hold
Price Target: $1.5 → $1
Current: $0.88
Upside: n/a
Aug 29, 2023
Maintained: Hold
Price Target: $0.4 → $0.25
Current: $20.19
Upside: n/a
May 24, 2023
Rated: Buy
Price Target: $63
Current: $70.52
Upside: n/a
Nov 28, 2022
Maintained: Buy
Price Target: $5 → $2
Current: $1.53
Upside: n/a
Sep 16, 2022
Maintained: Buy
Price Target: €12.00
Current: €1.78
Upside: n/a
Apr 5, 2022
Downgraded: Hold
Price Target: $30 → $8
Current: $58.92
Upside: n/a
Sep 27, 2021
Upgraded: Buy
Price Target: $8 → $11
Current: $9.11
Upside: n/a
Aug 21, 2019
Downgraded: Sell
Price Target: $26 → $2
Current: $1.22
Upside: n/a
Mar 20, 2019
Initiated Coverage: Hold
Price Target: $9
Current: $0.9194
Upside: n/a
Dec 29, 2016
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 13, 2015
Initiated Coverage: Hold
Price Target: n/a
Current: $0.00001
Upside: n/a
Apr 27, 2015
Rated: Hold
Price Target: n/a
Current: $6.82
Upside: n/a
Mar 31, 2015
Maintained: Buy
Price Target: $32
Current: $1.50
Upside: n/a
Mar 30, 2015
Reiterated: Buy
Price Target: $49
Current: $11.09
Upside: n/a
Mar 16, 2015
Reiterated: Buy
Price Target: $53
Current: $1.82
Upside: n/a
Jan 9, 2015
Initiated Coverage: Buy
Price Target: $10
Current: $1.12
Upside: n/a
Nov 23, 2014
Rated: Hold
Price Target: n/a
Current: $13.40
Upside: n/a
Nov 21, 2014
Rated: Hold
Price Target: n/a
Current: $2,366.00
Upside: n/a